美国 · SEC FORM 4
Harvard Apparatus Regenerative Technology, Inc.
HRGN · OTC · CIK 0001563665 · Healthcare · Packaged Foods
内部人信号
1 位买方 · 2 条买入交易行 · $394.5K 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是:CEO(CEO、董事长和持股 10% 以上的股东得分最低)
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
买方广度与集中度
Roles in the peak window: CEO. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
信号历史
最新留档分数
- 49.9
- 49.7
- 49.6
- 49.3
- 49.3
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- +17.3%
- 3M
- +119.0%
- 6M
- +46.3%
- 12M
- +18.6%
波动率与流动性
- 波动率
- 84.2%
- Beta
- —
- 平均每日成交额
- USD 3,081
估值
- 市值
- USD 40.4M
- P/E
- —
基本面
- 利润率
- -975.7%
- ROE
- -649.9%
- 细分行业
- Packaged Foods
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-10 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 625
- 上期报告
- 3,916
- 日均成交量
- 3,244
- 回补天数
- ≤ 1.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | He Junli | 买入 (P) | Common Stock | 6,725 | USD 2.15 | USD 14,459 | SEC 申报 ↗ |
| 2026-09-11 | He Junli | 买入 (P) | Common Stock | 361,905 | USD 1.05 | USD 380,000 | SEC 申报 ↗ |
| 2025-11-25 | He Junli | 买入 (P) | Common Stock | 3,000 | USD 1.70 | USD 5,100 | SEC 申报 ↗ |
| 2025-09-30 | He Junli | 买入 (P) | Common Stock | 300 | USD 1.98 | USD 594 | SEC 申报 ↗ |
| 2025-09-02 | He Junli | 买入 (P) | Common Stock | 11,225 | USD 1.85 | USD 20,766 | SEC 申报 ↗ |
| 2025-08-21 | He Junli | 买入 (P) | Common Stock | 4,050 | USD 1.72 | USD 6,966 | SEC 申报 ↗ |
| 2024-12-24 | He Junli | 买入 (P) | Common Stock | 2,299 | USD 2.87 | USD 6,598 | SEC 申报 ↗ |
| 2024-08-27 | He Junli | 买入 (P) | Common Stock | 5,101 | USD 3.37 | USD 17,190 | SEC 申报 ↗ |
| 2024-06-21 | He Junli | 买入 (P) | Common Stock | 1,600 | USD 2.80 | USD 4,480 | SEC 申报 ↗ |
| 2023-12-27 | He Junli | 买入 (P) | Common Stock | 2,700 | USD 4.76 | USD 12,852 | SEC 申报 ↗ |
| 2023-12-14 | He Junli | 买入 (P) | Common Stock | 900 | USD 4.92 | USD 4,428 | SEC 申报 ↗ |
| 2023-12-06 | He Junli | 买入 (P) | Common Stock | 1,500 | USD 5.07 | USD 7,605 | SEC 申报 ↗ |
| 2023-09-11 | He Junli | 买入 (P) | Common Stock | 1,500 | USD 5.43 | USD 8,145 | SEC 申报 ↗ |
| 2023-08-28 | He Junli | 买入 (P) | Common Stock | 3,400 | USD 4.69 | USD 15,946 | SEC 申报 ↗ |
| 2023-08-21 | Shmerling James E. | 买入 (P) | Common Stock | 6,864 | USD 4.35 | USD 29,858 | SEC 申报 ↗ |
Form 4 申报证据
4 transaction lines in the latest 365-day window; 37 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | He Junli | 买入 (P) | Common Stock | 6,725 | USD 2.15 | USD 14,459 | SEC 申报 ↗ |
| 2026-09-11 | He Junli | 买入 (P) | Common Stock | 361,905 | USD 1.05 | USD 380,000 | SEC 申报 ↗ |
| 2026-09-11 | He Junli | C (C) | Common Stock | 683,725 | USD 1.05 | USD 717,911 | SEC 申报 ↗ |
展开近期 Form 4 证据 (4 grouped rows)
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | HRGN |
| CIK | 0001563665 |
| 行业 | Healthcare |
| 细分行业 | Packaged Foods Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | OTC |
数据覆盖
| 本地 Form 4 历史 | 37 transaction lines from 2020-03-27 to 2026-09-15 23 P purchase lines · 4 S sale lines · 10 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.